Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
作者信息
Russell Michael Bjørn
出版信息
J Headache Pain. 2011 Apr;12(2):135-6. doi: 10.1007/s10194-011-0333-5. Epub 2011 Mar 27.
Abstract
摘要
相似文献
1
Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
J Headache Pain. 2011 Apr;12(2):135-6. doi: 10.1007/s10194-011-0333-5. Epub 2011 Mar 27.
2
OnabotulinumtoxinA for the treatment of chronic migraine.
Headache. 2011 Apr;51(4):659-60. doi: 10.1111/j.1526-4610.2011.01880.x.
3
Botulinum toxin-A is an effective and safe treatment for chronic migraine.
Headache. 2013 Jul-Aug;53(7):1165-7. doi: 10.1111/head.12120.
4
OnabotulinumtoxinA in Chronic Migraine: A Profile of Its Use.
CNS Drugs. 2020 Dec;34(12):1287-1298. doi: 10.1007/s40263-020-00776-8. Epub 2020 Dec 11.
5
Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.
J Headache Pain. 2011 Apr;12(2):137-8. doi: 10.1007/s10194-011-0334-4. Epub 2011 Apr 3.
6
OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.
7
OnabotulinumtoxinA for treatment of chronic migraine: a response.
Headache. 2011 Jun;51(6):1005-8. doi: 10.1111/j.1526-4610.2011.01925.x. Epub 2011 May 17.
8
Botulinum toxin type A (BOTOX) for treatment of migraine.
Dis Mon. 2002 May;48(5):323-35. doi: 10.1053/mda.2002.24423.
9
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program.
Headache. 2010 Oct;50(9):1406-18. doi: 10.1111/j.1526-4610.2010.01766.x.
10
OnabotulinumtoxinA for the treatment of chronic migraine not quite there. .
Cephalalgia. 2011 Feb;31(3):377; author reply 378-9. doi: 10.1177/0333102410388529. Epub 2010 Nov 22.
引用本文的文献
1
OnabotulinumtoxinA injections in chronic migraine, targeted to sites of pericranial myofascial pain: an observational, open label, real-life cohort study.
J Headache Pain. 2017 Dec;18(1):75. doi: 10.1186/s10194-017-0781-7. Epub 2017 Jul 21.
2
Peripheral endothelial function and arterial stiffness in patients with chronic migraine: a case-control study.
J Headache Pain. 2013 Jan 31;14(1):8. doi: 10.1186/1129-2377-14-8.
3
OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.
Drugs. 2012 Apr 16;72(6):825-45. doi: 10.2165/11208880-000000000-00000.
4
Chronic migraine plus medication overuse headache: two entities or not?
J Headache Pain. 2011 Dec;12(6):593-601. doi: 10.1007/s10194-011-0388-3. Epub 2011 Sep 22.
本文引用的文献
1
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17.
2
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17.
3
Reduction in medication-overuse headache after short information. The Akershus study of chronic headache.
Eur J Neurol. 2011 Jan;18(1):129-37. doi: 10.1111/j.1468-1331.2010.03094.x.
4
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
Headache. 2010 Jun;50(6):921-36. doi: 10.1111/j.1526-4610.2010.01678.x. Epub 2010 May 7.
5
Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria.
Cephalalgia. 2009 Apr;29(4):445-52. doi: 10.1111/j.1468-2982.2008.01753.x.
6
Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache.
Cephalalgia. 2008 Jul;28(7):705-13. doi: 10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.
7
Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus study of chronic headache.
Neuroepidemiology. 2008;30(2):76-83. doi: 10.1159/000116244. Epub 2008 Feb 14.
8
New appendix criteria open for a broader concept of chronic migraine.
Cephalalgia. 2006 Jun;26(6):742-6. doi: 10.1111/j.1468-2982.2006.01172.x.
9
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.
Cephalalgia. 2005 Jun;25(6):460-5. doi: 10.1111/j.1468-2982.2005.00878.x.
10
The International Classification of Headache Disorders: 2nd edition.
Cephalalgia. 2004;24 Suppl 1:9-160. doi: 10.1111/j.1468-2982.2003.00824.x.
Zotero 插件